1.A rare cause of acute abdomen-Spontaneous rectus sheath hematoma
Chong Chin Hock ; Chai Yih Feng ; Tan Eng Yew
Asian Pacific Journal of Tropical Biomedicine 2016;6(10):892-895
Spontaneous rectus sheath hematoma (SRSH) is a rare entity that mimics acute abdomen. Rectus sheath hematoma is the accumulation of blood in rectus sheath due to muscle or epigastric vessel injury. However, SRSH without a trauma or anticoagulation is rare. It frequently mimics acute abdomen and it may lead to misdiagnosis and unnecessary laparotomy. In this article, we described two cases of SRSH with their diagnostic and therapeutic strategy. Both of our patients in report were neither consumed antiplatelet nor coagulopathy. They both had abdominal muscle straining before their symptoms pre-sentation. We hypothesized that the SRSH may be induced by rectus muscle injury secondary to inappropriate straining or posture. To diagnose SRSH, clinical findings are important but radiologic imaging such as computed tomography, can be diagnostic. In expanding SRSH, percutaneous arterial embolization of epigastric artery is useful to secure the bleeding. If embolization is not feasible, surgical exploration hemostasis is curative. In non-expanding SRSH, it can be managed nonoperatively. SRSH is an important initial differential for acute abdomen. Radiologic imaging helps in diagnosis. Stable SRSH can be managed conservatively with good outcome.
2.Bioactive molecules: current trends in discovery, synthesis, delivery and testing
Yew Beng Kang ; Pichika R Mallikarjuna ; Davamani A Fabian ; Adinarayana Gorajana ; Chooi Ling Lim ; Eng Lai Tan
International e-Journal of Science, Medicine and Education 2013;7(supp1):S32-46
Important bioactive molecules are molecules
that are pharmacologically active derived from natural
sources and through chemical synthesis. Over the years
many of such molecules have been discovered through
bioprospective endeavours. The discovery of taxol from
the pacific yew tree bark that has the ability in stabilising
cellular microtubules represents one of the hallmarks of
success of such endeavours. In recent years, the discovery
process has been aided by the rapid development
of techniques and technologies in chemistry and
biotechnology. The progress in advanced genetics and
computational biology has also transformed the way
hypotheses are formulated as well as the strategies for drug
discovery. Of equal importance is the use of advanced
drug delivery vehicles in enhancing the efficacy and
bioavailability of bioactive molecules. The availability of
suitable animal models for testing and validation is yet
another major determinant in increasing the prospect for
clinical trials of bioactive molecules.
3.Healthcare cost of patients with multiple chronic diseases in Singapore public primary care setting.
Shu Yun TAN ; Kaiwei Jeremy LEW ; Ying XIE ; Poay Sian Sabrina LEE ; Hui Li KOH ; Yew Yoong DING ; Eng Sing LEE
Annals of the Academy of Medicine, Singapore 2021;50(11):809-817
INTRODUCTION:
The rising prevalence of multiple chronic diseases is an important public health issue as it is associated with increased healthcare utilisation. This paper aimed to explore the annual per capita healthcare cost in primary care for patients with multiple chronic diseases (multimorbidity).
METHODS:
This was a retrospective cohort study conducted in a cluster of public primary care clinics in Singapore. De-identified data from electronic medical records were extracted from July 2015 to June 2017. Only patients with at least 1 chronic disease were included in the study. Basic demographic data and healthcare cost were extracted. A list of 20 chronic diseases was considered for multimorbidity.
RESULTS:
There were 254,377 patients in our study population, of whom 52.8% were female. The prevalence of multimorbidity was 62.4%. The median annual healthcare cost per capita for patients with multimorbidity was about twice the amount compared to those without multimorbidity (SGD683 versus SGD344). The greatest percentage increment in cost was when the number of chronic diseases increased from 2 to 3 (43.0%).
CONCLUSION
Multimorbidity is associated with higher healthcare cost in primary care. Since evidence for the optimal management of multimorbidity is still elusive, prevention or delay in the onset of multimorbidity in the general population is paramount.
Chronic Disease
;
Comorbidity
;
Cross-Sectional Studies
;
Female
;
Health Care Costs
;
Humans
;
Prevalence
;
Primary Health Care
;
Retrospective Studies
;
Singapore/epidemiology*
4. A rare cause of acute abdomen – Spontaneous rectus sheath hematoma
Hock Chin CHONG ; Feng Yih CHAI ; Yew Eng TAN ; Sophia Si Ling HENG ; Siti Asilah MOHD DESA
Asian Pacific Journal of Tropical Biomedicine 2016;6(10):892-895
Spontaneous rectus sheath hematoma (SRSH) is a rare entity that mimics acute abdomen. Rectus sheath hematoma is the accumulation of blood in rectus sheath due to muscle or epigastric vessel injury. However, SRSH without a trauma or anticoagulation is rare. It frequently mimics acute abdomen and it may lead to misdiagnosis and unnecessary laparotomy. In this article, we described two cases of SRSH with their diagnostic and therapeutic strategy. Both of our patients in report were neither consumed antiplatelet nor coagulopathy. They both had abdominal muscle straining before their symptoms presentation. We hypothesized that the SRSH may be induced by rectus muscle injury secondary to inappropriate straining or posture. To diagnose SRSH, clinical findings are important but radiologic imaging such as computed tomography, can be diagnostic. In expanding SRSH, percutaneous arterial embolization of epigastric artery is useful to secure the bleeding. If embolization is not feasible, surgical exploration hemostasis is curative. In non-expanding SRSH, it can be managed nonoperatively. SRSH is an important initial differential for acute abdomen. Radiologic imaging helps in diagnosis. Stable SRSH can be managed conservatively with good outcome.